Clinical Trial for PTEN-deficient Mets progressing on trastuzumab-based therapy
Phase I-II Study of Trastuzumab in Combination With RAD001 in Patients With HER-2 Overexpressing, PTEN-Deficient Metastatic Breast Cancer Progressing on Trastuzumab-Based Therapy
This study is currently recruiting patients. Verified by M.D. Anderson Cancer Center May 2006 http://www.clinicaltrials.gov/ct/gui...17720?order=13 |
This one, in my opinion, is worth signing-up for. And because it is phase 1 / 2, you will always be in the drug arm of the trial.
Al |
al, what is rad001?
does anyone know what the drug rad001 is? or what class of drug it is? i agree this looks like a very interesting trial, if only i knew the combination they are testing.
thanks for any info, sara |
I am very new to this forum and wanted to know how can one get PTEN tested ? I have read in some of the posts that few people did get theit PTEN tested. Could someone please let me know how and where was it done, is it a blood test ?
|
All times are GMT -7. The time now is 05:16 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021